Xultophy (insulin degludec/liraglutide)
Status:
Concluded without agreement
Manufacturer:
Novo Nordisk Canada Inc.
Indication:
Diabetes Mellitus, Type 2
Last updated April 26, 2021
Status:
Concluded with an LOI
Manufacturer:
Sandoz Canada Inc.
Indication:
Deep vein thrombosis (treatment and prevention)
Last updated April 15, 2021
Status:
Concluded with an LOI
Manufacturer:
Pfizer Canada ULC
Indication:
Febrile neutropenia in non-myeloid malignancies
Last updated April 5, 2021
Status:
Concluded with an LOI
Manufacturer:
Valeo Pharma Inc.
Indication:
Deep-Vein Thrombosis (treatment), without Symptomatic Pulmonary Embolism
Last updated March 24, 2021
Status:
Concluded without agreement
Manufacturer:
Eli Lilly Canada Inc.
Indication:
Ankylosing spondylitis
Last updated March 19, 2021
Status:
Concluded without agreement
Manufacturer:
Amgen Canada Inc.
Indication:
Psoriatic Arthritis
Last updated March 17, 2021
Status:
Concluded without agreement
Manufacturer:
Amgen Canada Inc.
Indication:
Psoriasis, moderate to severe plaque
Last updated March 17, 2021
Status:
Concluded with an LOI
Manufacturer:
Astellas Pharma Inc.
Indication:
Acute Myeloid Leukemia (AML)
Last updated March 15, 2021
Blood glucose test strips (blood glucose test strips)
Status:
Concluded with an LOI
Manufacturer:
Skymed Monitors Inc.
Indication:
Diabetes Mellitus, Type 1 & 2
Last updated February 26, 2021
Status:
Concluded with an LOI
Manufacturer:
Sanofi Genzyme Canada
Indication:
Atopic dermatitis
Last updated February 25, 2021